August 2021 - Page 4 of 6 - BioMedWire (BMW)

ThursdayAug 12, 2021 11:33 am

Anpac Bio Continues Growth Trajectory

In recent years, advances in technology have led to demand for early cancer testing and screening methods that are less invasive and lower cost. Insurance companies have accepted that traditional testing methods are labor intensive and are not ideal as the first line of defense when screening and diagnosing cancer. This has opened a multi-billion-dollar market opportunity in discovering new solutions to tackle cancer and disease testing outside of traditional diagnostics that have been used for generations without any major upgrades or breakthroughs. AnPac Bio-Medical Science Co., Ltd. (ANPC.US), a biotechnology company focused on early cancer screening and detection as…

ThursdayAug 12, 2021 10:48 am

Fluorescent Imaging Agent May Allow for Better Cervical Cancer Detection

Recently conducted research has discovered that cervical cancer can be detected by clinicians using a handheld microscope and a topical fluorescent imaging agent dubbed PARPi-FL. This imaging technique targets the PARP1 enzyme, which is overexpressed in this type of cancer. It has the potential to revolutionize cervical cancer biopsies and screenings. Cervical cancer is the fourth most common cancer in women. Data shows that in 2018, nearly 600,000 women were diagnosed with this cancer type globally, with roughly 310,000 of them succumbing to the disease. Almost 99% of cervical cancer cases are caused by human papilloma virus (“HPV”), which can…

WednesdayAug 11, 2021 10:29 am

Brain Fingerprints May Facilitate Neurological Disease Detection

A scientist at EPFL (the Swiss Federal Institute for Technology) has discovered that it is possible to detect declining cognitive function by using the fingerprints of an individual’s brain. Brain fingerprints refer to the neural connections’ map as detected by brain imaging techniques. The scientist stumbled upon this discovery after noticing that the brain fingerprints in individuals suffering from cognitive decline are more difficult to detect compared to how easily the brain fingerprints of healthy subjects can be detected. Just as is the case with fingers, the brain of each individual has a unique pattern that is embedded within it,…

TuesdayAug 10, 2021 12:37 pm

Scientists Can Use Blood Plasma, Urine Tests to Detect Brain Tumors

Scientists from the Cancer Research UK Cambridge Institute have designed tests that can detect the presence of a type of brain tumor known as a glioma via a patient’s blood plasma or urine. The group notes that this test is the first of its kind globally, adding that its results, which only included a handful of patients, are promising. The research is currently in its early stages and was published in “EMBO Molecular Medicine.” Brain tumor recurrence in individuals who have already had a brain tumor removed is high, which is why monitoring patients using an MRI scan is important.…

TuesdayAug 10, 2021 11:04 am

Brain Scientific Inc. (BRSF) Addresses Critical Neurologist Shortfall with Cost-Effective, Portable Brain Diagnostic Devices

American Academy of Neurology warns of critical neurologist shortfall amid increased incidence of brain disorders Brain Scientific addresses issue with portable, cost-effective brain diagnostic solutions that record EEGs in nearly any setting Product development includes creation of AI and ML algorithms to detect seizures, dementia and other brain-related conditions NeuroCap and NeuroEEG device patents approved in U.S., Europe and China With a goal of addressing the current acute neurologist shortfall in the United States (https://ibn.fm/DrxvC), Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, has developed cost-effective and portable proprietary medical devices that are positioned to disrupt the electroencephalogram (“EEG”)…

MondayAug 09, 2021 1:57 pm

How to Make Remote Healthcare Better for Everyone as Implementation Spreads

Even before the coronavirus pandemic began, remote healthcare was on the rise. Remote healthcare, which is fast becoming the preferred way to deliver healthcare, has many benefits including reducing costs and freeing up healthcare facilities for critical needs. It also provides more meaningful and robust data. Many view remote healthcare as more effective and efficient at tracking the health of patients in their natural environment, with physicians noting that more accurate data leads to better outcomes. Moving standard medical visits online also offers patients more flexibility and physicians more time to prepare for a more efficient and higher value interaction…

MondayAug 09, 2021 1:12 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise

InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates back to November 2020 InMed looks to capitalize on the growing cannabinoid industry that is projected to grow at a CAGR of 21.2% from 2021 to 2028 InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company committed to developing cannabinoid-based pharmaceutical drug candidates. It also manufactures technologies for pharmaceutical-grade rare cannabinoids. It is known for creating a pipeline of cannabinoid-based pharmaceutical drug candidates to treat various…

MondayAug 09, 2021 12:10 pm

Brain Scientific Inc. (BRSF) Positioned to Disrupt EEG Market with Cost-Effective Brain Imaging Devices

Brain Scientific poised to disrupt neurology market with two new FDA-cleared patented products that provide cost-effective brain imaging in any setting Current global market for EEG devices estimated at $956.1 million with CAGR of 8.7% from 2019 to 2026, expected to reach $1.6 billion by 2026 With a focus on developing innovative and proprietary medical devices and software, Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is fulfilling its mission of modernizing and increasing accessibility to brain diagnostics with two new FDA-cleared products that provide next-generation solutions to the neurology market. Already patented in the United States, China and…

FridayAug 06, 2021 1:35 pm

New Model Could Result in More Customized Bladder Cancer Treatments

Researchers from the Uppsala University have developed a new mouse model that can be used to study the factors that contribute to the progression of immune-system activation and bladder cancer in humans as the tumor grows. Through this model, the researchers have learned how proteins change prior to, during and after tumor development in the bladder wall. Their findings were published in the “PLOS ONE” journal. The study’s principal investigator Sara Mangsbo stated that the model was designed to demonstrate the harmful mutations observed in bladder cancer patients and to contain mutations that drive tumor growth, known as specific oncogenes.…

FridayAug 06, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Testing Volume Increase for First Half of 2021

Total number of paid tests and paid cancer tests increased significantly in Q2 over Q1 The company’s approach to multi-cancer screening is called Cancer Differentiation Analysis (“CDA”) that is powered by a database of over 200,000 samples and cases, changing the way to approach disease and cancer screenings The global cancer diagnostics market size is expected to reach $249.6 billion by 2026, growing at a CAGR of 7% during the forecast period AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company focused on early cancer screening, detection, and cancer treatment, announced that it experienced strong growth in test volume in the…